Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COBRA: Combining fertility preservation interventions before chemotherapy in breast cancer
2020-005914-16Phase 2Completed
- Sponsor
- UZ Brussel
- Start
- Feb 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label trial of corifollitropin alfa and follitropin beta in breast cancer and infertility (2 arms), sponsored by UZ Brussel. Primary endpoint: Mature oocyte yield. Started Feb 2021; status: completed.
02
Drugs
corifollitropin alfafollitropin beta
03
Conditions
breast cancerinfertility
Beyond the preview
Go deeper on 2020-005914-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-005914-16.